Science and diplomacy for global health

Science and diplomacy for global health

Up next

Bonus episode: Podcasts for sparking conversations on global health

The growing popularity of podcasts as an innovative platform for sharing experiences and views on a wide range of topics was one of the inspirations for starting Global Health Matters. As engaging and learning from our stakeholders is one of our goals, we invited some ...

  Show more

Decolonization, localization and WHO - History matters part 1

In this episode we explore the multifaceted history of global health and how the narratives borne out of colonization, geopolitical events, and national ownership of public health inform policy and practices today. Among the narratives is that of the World Health Organization, ...

  Show more

Recommended Episodes

Introduction to Global Health
The Rx Bricks Podcast

<h2 id="header-9c83a0c4947a4ff482f264ddb56bfda5" class="brick-header brick-header-primary markup-enabled medium-editor-element" role="textbox" data-rxannotationdata="content.text" data-medium-editor-element="true" aria-multiline="true" data-medium-editor-editor-index="1" data-pla ...  Show more

Let's Diagnose Global Health Today | Dr Slim Slama
The afikra Podcast

The CEO of the World Innovation Summit for Health (WISH), Dr Slim Slama, joins us on this episode of The afikra Podcast to give an in-depth look into the complexities and challenges facing global health today, including the rise of non-communicable diseases, the impact of urba ...

  Show more

Youth skills in a rapidly changing world
Our World, Connected

Meet Dr John Mugo and Beria Wawira – two colleagues on a mission to empower millions of young people and parents through the Zizi Afrique Foundation in Kenya. In conversation with host Christine Wilson, they ask: are we preparing young people for success in today’s fast-paced ...

  Show more

#22 Reforming pharmacovigilance education – Michael Reumerman
Drug Safety Matters

Send a text message to the show!Healthcare professionals are key players in medicines safety but they often lack the time or knowledge to report adverse drug reactions. To change that, we need to urgently rethink how we teach pharmacovigilance, argues Michael Reumerman from Amste ...  Show more